JUSH

Jushi Holdings Inc.
2 filings tracked
healthcarebiotechnologySMALL ($300M-2B)

Signal Magnitude Chart

BULLISH | 80% | 5/12/2026 | margin expansionBULLISH | 70% | 5/12/2026 | debt restructureBEARISH | 60% | 5/12/2026 | earnings missBULLISH | 90% | 5/12/2026 | regulatory actionBULLISH | 80% | 5/12/2026 | margin expansionBULLISH | 70% | 5/12/2026 | debt restructureBEARISH | 60% | 5/12/2026 | earnings missBULLISH | 90% | 5/12/2026 | regulatory actionMay 26May 26HIGHLOW
bullish
bearish
neutral

Signal Timeline

bullishMay 12

Gross profit margin expanded from 40% to 45% YoY.

margin expansion
80%
bullishMay 12

Refinanced near-term debt into a $160M term loan maturing in 2029.

debt restructure
70%
bearishMay 12

Net loss widened to $19.8M from $17M in the prior year period.

earnings miss
60%
bullishMay 12

DOJ reclassified medical cannabis to Schedule III, potentially easing 280E tax burdens.

regulatory action
90%
bullishMay 12

Gross profit margin expanded from 40% to 45% YoY.

margin expansion
80%
bullishMay 12

Refinanced near-term debt into a $160M term loan maturing in 2029.

debt restructure
70%
bearishMay 12

Net loss widened to $19.8M from $17M in the prior year period.

earnings miss
60%
bullishMay 12

DOJ reclassified medical cannabis to Schedule III, potentially easing 280E tax burdens.

regulatory action
90%